Ikarian Capital’s Vigil Neuroscience VIGL Stock Holding History

Ikarian Capital’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31,360	Closed	-$249K	–	197
2025 Q2	$249K	Sell	31,360 -218,640	-87%	-$980K	0.05%	105
2025 Q1	$445K	Sell	250,000 -250,000	-50%	-$561K	0.05%	119
2024 Q4	$850K	Buy	+500,000	New	+$1.48M	0.12%	114

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Ikarian Capital's VIGL Position: Q3 2025 in Review

Ikarian Capital sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 31,360 shares — an estimated $249K sold.

Ikarian Capital first reported a position in VIGL in Q4 2024 and held it in 3 quarters. The position peaked at $850K in Q4 2024. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Ikarian Capital reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Ikarian Capital sold 31,360 Vigil Neuroscience shares in Q3 2025, an estimated $249K.
Ikarian Capital first reported a position in Vigil Neuroscience in Q4 2024 and held it in 3 quarters.
Ikarian Capital's Vigil Neuroscience position peaked at $850K in Q4 2024.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Ikarian Capital's 13F filing for Q3 2025, filed 14 Nov 2025.